Related Experiment Videos
Anabolic effects of fluoride on bone
C Y Pak1, J E Zerwekh, P Antich
1Center for Mineral Metabolism and Clinical Research, The University of Texas Southwestern Medical Center, Dallas 75235-8885, USA.
Trends in Endocrinology and Metabolism: TEM
|September 1, 1995
Summary
Fluoride has beneficial effects on bone at low doses but can harm bone quality at high doses. A new slow-release sodium fluoride treatment may offer therapeutic benefits for osteoporosis without toxicity.
Area of Science:
- Bone biology and osteoporosis treatment.
- Pharmacology of fluoride compounds.
Background:
- Fluoride exhibits a biphasic effect on bone health, influencing osteoblasts, bone mineral, and overall bone structure.
- Low fluoride concentrations are beneficial for bone, while higher concentrations can lead to impaired bone mineralization and quality.
Purpose of the Study:
- To investigate a novel therapeutic approach for postmenopausal osteoporosis using fluoride.
- To evaluate the efficacy and safety of an intermittent slow-release sodium fluoride (SR-NaF) regimen combined with calcium citrate.
Main Methods:
- The study explores the dual action of fluoride on bone metabolism and mineralization.
- A new treatment protocol involving intermittent slow-release sodium fluoride (SR-NaF) and continuous calcium citrate was designed.
Main Results:
- Low fluoride levels promote beneficial skeletal effects.
- High fluoride levels and uptake can result in abnormally mineralized bone with compromised quality.
- The proposed SR-NaF regimen aims to harness fluoride's therapeutic potential while mitigating adverse effects.
Conclusions:
- Intermittent slow-release sodium fluoride (SR-NaF) with calcium citrate presents a promising strategy for treating postmenopausal osteoporosis.
- This approach may achieve therapeutic efficacy by optimizing fluoride delivery and minimizing toxic effects on bone quality.